PROVIDER PROFILE · NPI 1942464896

Shadia JalalMD

Hematology-OncologyIndianapolis, INI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

103

Unique beneficiaries

—

Total services

280

Distinct HCPCS

Medicare payment

$19K

Peer benchmark

Total Medicare services vs. 177 Hematology-Oncology providers in IN — bottom quintile (cohort median 1,010).

PRESCRIBING · PART D · 2024

Total Rx claims

361

Beneficiaries

—

Total drug cost

$1.0M

Distinct drugs

Brand share

29.6%

Top prescribed drugs

Osimertinib Mesylate47 claims

Omeprazole42 claims

Dexamethasone42 claims

Apixaban37 claims

Levothyroxine Sodium36 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Shadia Jalal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
INDIANA UNIVERSITY HEALTH INC	123	2,934
Sonal Majmundar Diagnostic Radiology · Lafayette, IN	28	123
Shawn Teague Radiation Oncology · Indianapolis, IN	16	45
Vasantha Aaron Diagnostic Radiology · Indianapolis, IN	14	37
Fatih Akisik Diagnostic Radiology · Indianapolis, IN	13	43
Nasser Hanna Hematology-Oncology · Indianapolis, IN	13	120
John Dewitt Gastroenterology · Indianapolis, IN	11	39

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history